BG101325A - Use of muramyl peptide compounds - Google Patents
Use of muramyl peptide compoundsInfo
- Publication number
- BG101325A BG101325A BG101325A BG10132597A BG101325A BG 101325 A BG101325 A BG 101325A BG 101325 A BG101325 A BG 101325A BG 10132597 A BG10132597 A BG 10132597A BG 101325 A BG101325 A BG 101325A
- Authority
- BG
- Bulgaria
- Prior art keywords
- treatment
- peptide compounds
- muramyl
- muramyl peptide
- conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9419011A GB9419011D0 (en) | 1994-09-21 | 1994-09-21 | Use of muramyl peptide compounds |
| PCT/GB1995/002237 WO1996009063A1 (en) | 1994-09-21 | 1995-09-20 | Use of muramyl peptide compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG101325A true BG101325A (en) | 1998-01-30 |
Family
ID=10761674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG101325A BG101325A (en) | 1994-09-21 | 1997-03-13 | Use of muramyl peptide compounds |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0782454A1 (ja) |
| JP (1) | JPH10506387A (ja) |
| KR (1) | KR970706015A (ja) |
| AU (1) | AU3527495A (ja) |
| BG (1) | BG101325A (ja) |
| CA (1) | CA2200570A1 (ja) |
| CZ (1) | CZ86197A3 (ja) |
| GB (1) | GB9419011D0 (ja) |
| HU (1) | HUT77741A (ja) |
| IL (1) | IL115391A0 (ja) |
| SK (1) | SK36697A3 (ja) |
| WO (1) | WO1996009063A1 (ja) |
| ZA (1) | ZA957997B (ja) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6693396A (en) * | 1995-08-08 | 1997-03-05 | Allergan, Inc. | Method of increasing tear production by topical administration of muramyl peptide |
| DE10106852A1 (de) * | 2001-02-14 | 2002-09-05 | T Luger | Entzündungshemmende Verbindungen |
| CN108785251B (zh) * | 2018-01-23 | 2020-11-24 | 盛元医药广州有限公司 | 一种眼用药物组合物及其制备方法和应用 |
| MX2023011004A (es) | 2021-03-19 | 2024-01-08 | Trained Therapeutix Discovery Inc | Compuestos para regular la inmunidad entrenada y métodos para usarlos. |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0026746B1 (de) * | 1979-10-02 | 1985-04-10 | Ciba-Geigy Ag | Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung |
| EP0056560A1 (de) * | 1981-01-19 | 1982-07-28 | Ciba-Geigy Ag | Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika |
| EP0102319B1 (de) * | 1982-07-23 | 1987-08-19 | Ciba-Geigy Ag | Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen |
| JPH04506808A (ja) * | 1989-07-19 | 1992-11-26 | ジ・アップジョン・カンパニー | 転移状態擬態としてのジアミノグリコール類を含有するペプチド類 |
| US5506204A (en) * | 1991-11-19 | 1996-04-09 | Peptech (Uk) Limited | Muramyl compounds for treatment of septic shock |
| US5679348A (en) * | 1992-02-03 | 1997-10-21 | Cedars-Sinai Medical Center | Immunotherapy for recurrent HSV infections |
| MX9301789A (es) * | 1992-04-03 | 1993-10-01 | Iaf Biochem Int | Nuevos oligopeptidos lipofilicos con actividad inmunomoduladora. |
-
1994
- 1994-09-21 GB GB9419011A patent/GB9419011D0/en active Pending
-
1995
- 1995-09-20 EP EP95932084A patent/EP0782454A1/en not_active Withdrawn
- 1995-09-20 KR KR1019970701823A patent/KR970706015A/ko not_active Application Discontinuation
- 1995-09-20 AU AU35274/95A patent/AU3527495A/en not_active Abandoned
- 1995-09-20 CZ CZ97861A patent/CZ86197A3/cs unknown
- 1995-09-20 JP JP8510688A patent/JPH10506387A/ja active Pending
- 1995-09-20 CA CA002200570A patent/CA2200570A1/en not_active Abandoned
- 1995-09-20 HU HU9800756A patent/HUT77741A/hu unknown
- 1995-09-20 SK SK366-97A patent/SK36697A3/sk unknown
- 1995-09-20 WO PCT/GB1995/002237 patent/WO1996009063A1/en not_active Application Discontinuation
- 1995-09-21 ZA ZA957997A patent/ZA957997B/xx unknown
- 1995-09-21 IL IL11539195A patent/IL115391A0/xx unknown
-
1997
- 1997-03-13 BG BG101325A patent/BG101325A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL115391A0 (en) | 1995-12-31 |
| WO1996009063A1 (en) | 1996-03-28 |
| JPH10506387A (ja) | 1998-06-23 |
| GB9419011D0 (en) | 1994-11-09 |
| EP0782454A1 (en) | 1997-07-09 |
| HUT77741A (hu) | 1998-07-28 |
| CA2200570A1 (en) | 1996-03-28 |
| CZ86197A3 (en) | 1997-08-13 |
| KR970706015A (ko) | 1997-11-03 |
| SK36697A3 (en) | 1997-11-05 |
| ZA957997B (en) | 1997-03-24 |
| AU3527495A (en) | 1996-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG102425A (en) | (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors | |
| LU90856I2 (fr) | Uprima - apomorphine hydrochloride et ses d-riv-s pharmaceutiquement acceptables | |
| BG100974A (en) | Vaccines against papillomavirus | |
| GB9406857D0 (en) | Improvements in or relating to organic compounds | |
| GB9907461D0 (en) | Neurite regeneration | |
| PL319833A1 (en) | Compounds and composition for carrying active media | |
| DE69731373D1 (de) | Cc-chemokinzeptor c-c ckr-5, dessen derivate und verwendungen | |
| BG95935A (bg) | Метод и средство за приемане на дексмедетомидин директно през кожата | |
| GR3023233T3 (en) | Inhibitors of dipeptidyl-aminopeptidase type iv | |
| CA2075060A1 (en) | Novel vehicle gases and their use in medical preparations | |
| AU3380797A (en) | Hypodermic injector system and method for maintaining the sterility thereof prior to use | |
| UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
| AU5727296A (en) | 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents | |
| ES2134801T3 (es) | Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso. | |
| BR0009524A (pt) | Uso de um composto, e, composição farmacêutica ou veterinaria | |
| CA2254682A1 (en) | Method of treating eye infections with azithromycin | |
| DE69311541D1 (de) | Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten | |
| SE9402880D0 (sv) | New peptide derivatives | |
| AU3717995A (en) | Mutant activated gsalpha* and adenylyl cyclase 2 for use as therapeutic agents | |
| BG101325A (en) | Use of muramyl peptide compounds | |
| MX9707875A (es) | Levobupivacaina y su uso como un anestesico en mujeres embarazadas. | |
| GB2324091A (en) | Metalloproteinase inhibitors | |
| HU9700661D0 (en) | Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer | |
| EP0971725A4 (en) | METHOD FOR TREATING SCAR TISSUE | |
| AU3600199A (en) | A pharmaceutical composition containing ezrin mutated on tyrosine 353 |